Dug Study Psyche
Dug Study Psyche
1. Antipsychotic drugs
a. Typical Drugs
PO body
restlessness
excitement or
increased activity
depression
inappropriate
happiness
breast
enlargement
breast milk
production
menstrual period
changes (missed
periods or heavy
bleeding)
changes in sex
drive
increase in precipitate
12.5-mg dizziness,
increments. gastritis, nausea,
Maximum vomiting,
dose: 100 mg.c tremors. Blood
dyscrasias,
particularly
agranulocytosis,
mild leukopenia,
may occur. May
lower seizure
threshold.
always be
started on the
lower dosage.)
b. Typical Drugs:
dopami
bone marrow function, CNS depression (common side effect).
Brand history of clozapine- (sedation, delirium, Monitor CBC for blood
name induced agranulocytosis coma), respiratory dyscrasias.
ne
Clozaril
Classificati
or severe
granulocytopenia,
myeloproliferative
depression,
hypersalivation. Blood
dyscrasias, particularly
Supervise suicidal-risk pt
closely during early therapy
(as depression lessens,
on
receptor
Antipsychotic
disorders, paralytic
ileus, uncontrolled
seizures, severe CNS
agranulocytosis, mild
leukopenia, may
occur.
energy level improves,
increasing suicide potential).
Assess for therapeutic
uency
s in the
Dosage
Route/freq
depression, coma.
Cautions: History of
seizures, cardiovascular
response (interest in
surroundings, improvement
in self-care, increased ability
Tablets brain,
disease, myocarditis; to concentrate, relaxed facial
respiratory, hepatic, expression).
depress
renal impairment; Do not abruptly discontinue
– 25,
alcohol withdrawal; long-term drug therapy.
high risk of suicide; Drowsiness generally
100mg; es the
paralytic ileus; subsides during continued
myasthenia gravis; pts therapy.
at risk for aspiration Avoid tasks that require
orally RAS;
pneumonia; urinary alertness, motor skills until
retention; narrow-C response to drug is
underlined – top established.
disinteg antichol
prescribed drug 272 Avoid alcohol, caffeine.
clozapine angle Report fever, sore throat,
glaucoma; prostatic flu-like symptoms.
PUROC, LIZA M.
rating inergic,
hypertrophy;
xerostomia; visual
disturbances;
tablets antihist
constipation; history of
bowel obstruction;
diabetes mellitus.
25, and
50, 100 alpha-
mg adrener
Tablets gic
– 25, blockin
100mg; g
orally activity
disinteg may
rating contrib
PUROC, LIZA M.
tablets ute to
– 12.5, some of
25, its
50, 100 therape
mg utic
(and
PO: ADULTS:
Initially, 12.5 mg
once or twice a
adverse
day. May increase
by 25–50 mg/ day
over 2 wks until
dosage of 300–450
mg/day is
achieved. May
)
further increase by
50–100 mg/day no
more than once or
actions.
twice a week.
Range: 200–600
mg/day.
Clozapi
Maximum: 900
mg/day. ne
produce
ELDERLY: Initially,
25 mg/day. May
increase by 25 mg/
PUROC, LIZA M.
s
day.
Maximum: 450
mg/day
fewer
extrapy
ramidal
effects
than
other
antipsy
chotics.
Blocks
dopami
ne
PUROC, LIZA M.
receptor
s in the
brain,
depress
es the
RAS;
antichol
inergic,
antihist
aminic,
and
alpha-
PUROC, LIZA M.
adrener
gic
blockin
g
activity
may
contrib
ute to
some of
its
therape
utic
PUROC, LIZA M.
(and
adverse
)
actions.
Clozapi
ne
produce
s
fewer
extrapy
ramidal
effects
PUROC, LIZA M.
than
other
antipsy
chotics.
Interferes with binding
of dopamine at
dopamine receptor
sites; binds primarily at
nondopamine receptor
sites.
Therapeutic Effect:
Diminishes
schizophrenic behavior
Brand
name
Classificati
PUROC, LIZA M.
on
Dosage
Route/freq
uency
risperidone
Brand
name
Classificati
on
Dosage
PUROC, LIZA M.
Route/freq
uency
olanzapine
Brand
name
Classificati
on
Dosage
Route/freq
PUROC, LIZA M.
uency
quetiapine
Brand
name
Classificati
on
Dosage
Route/freq
uency
PUROC, LIZA M.
ziprasidone
Brand
name
Classificati
on
Dosage
Route/freq
uency
PUROC, LIZA M.
aripiprazole
Brand
name
Classificati
on
Dosage
Route/freq
uency
PUROC, LIZA M.
asenapine
Brand
name
Classificati
on
Dosage
Route/freq
uency
PUROC, LIZA M.
Brand
name
Classificati
on
Dosage
Route/freq
uency
PUROC, LIZA M.
Brand
name
Classificati
on
Dosage
Route/freq
uency
PUROC, LIZA M.
Brand
name
Classificati
on
Dosage
Route/freq
uency
1. Antipsychotic drugs
PUROC, LIZA M.
a. Typical
b. Atypical
c. New generation antipsychotics
d.
2. Anti-depressant drugs
a. Tricyclic antidepressants (TCA)
b. Selective serotonin reuptake inhibitors (SSRI)
c. Monoamine oxidase inhibitors (MAOI)
3. Anti-anxiety drugs (anxiolytics)